Less than a year after investing heavily in Minnesota-based Anteris Technologies, Medtronic has announced a new strategic investment in Pi-Cardia. The TAVR technology at the heart of this investment is Pi-Cardia's FDA-approved ShortCut device. 

The question is further complicated by possibly needing different thresholds for pregnant, premenopausal, and postmenopausal woman.

Clinicians who dedicate their lives to helping others may not always take care of their own health, according to new data presented at ESC Congress 2026.

New late-breaking data presented at ESC Congress 2026 adds to the growing evidence that more invasive catheter-based pulmonary embolism procedures can improve patient outcomes.

There is no question metformin is an effective medication for patients with type 2 diabetes. When it comes to treating heart failure, however, it falls short.

Many patients who need TAVR also present with coronary artery disease. According to new data presented at ESC Congress 2026, performing TAVR first is noninferior to performing PCI first. 

While T-TEER is already known to improve a patient's quality of life, this late-breaking study from ESC Congress 2026 confirmed it also improves survival and reduces the risk of heart failure hospitalization.

It was a relatively small study, and patients were only followed for six months, but these late-breaking data out of ESC Congress 2026 give care teams a lot to consider. 

“Our findings do not support routine electrical mapping to target left ventricular lead placement in contemporary CRT practice,” one researcher said. 

New data presented at ESC Congress 2026 represent a huge breakthrough for patients with nonobstructive HCM. "For the first time, we have shown clinically meaningful improvements in symptoms and exercise capacity with a treatment that targets the cause of the disease," one researcher explained. 

AI technology developed by Caristo Diagnostics was the focus of multiple studies presented at ESC Congress 2026.

iRhythm has agreed to acquire VitalConnect for approximately $237.5 million in cash and another $50 million in common stock.

Robert L. Frye, MD, spent more than 60 years with Mayo Clinic. He was also a former president of the American College of Cardiology.

Johnson & Johnson MedTech and Oscor, the company’s manufacturing partner, received reports of the sheaths leaking in ways that could result in access-site bleeding. 

Founded in 2017, the service seeks to connect patients, providers and imaging centers—matching parties based on scanner availability, quality and price. 

The general public is smiling at local healthcare providers while snarling at federal healthcare agencies, according to a survey report posted Aug. 31 by Annenberg Public Policy Center at the University of Pennsylvania.